Gedeon Richter Pays $263.5m For Ex-US Rights To Janssen’s Evra

‘Milestone Deal’ Will Unfold ‘Significant Synergies’

Hungarian firm Gedeon Richter is to expand further its sizeable women’s health portfolio after agreeing to acquire Janssen’s Evra (ethinyl estradiol/norelgestromin) transdermal patch outside of the US for more than a quarter of a billion dollars.

Handshake of businessmen
Richter has further strengthened its presence in women's healthcare. • Source: Shutterstock

Gedeon Richter is to enhance its existing branded female healthcare franchise worldwide and tap into transdermal patch formulations after signing an agreement to acquire Janssen’s Evra (ethinyl estradiol/norelgestromin) outside of the US for $263.5m.

The Johnson & Johnson subsidiary is to provide support to Richter to smooth the transfer of the marketing authorizations, including...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business